NanoPass Technologies

Company Overview

Snapshot

Founded in April 2000 by Shuki Yeshurun, NanoPass Technologies operates with 11–50 employees. The company has raised a total of $14.1M across 6 funding rounds from 6 investors. In July 2024, NanoPass Technologies secured a $4M investment from Awz Ventures.

Business overview

NanoPass Technologies specializes in developing cutting-edge solutions for intradermal delivery, leveraging proprietary technology to enhance therapeutic and medical aesthetic procedures. The company's core product, the MicronJet™ intradermal delivery platform, is designed to provide precise, safe, and efficient drug administration. NanoPass Technologies operates within the Health Tech & Life Sciences sector, focusing on areas such as drug delivery, medical devices, and medical treatment and therapeutics.

Strategic signal

In January 2026, NanoPass Technologies is set to launch its MicronJet™ 800 during IMCAS World 2026, expanding its product portfolio. This launch signals the company's continued innovation and commitment to advancing intradermal delivery technology, indicating a focus on product development and market expansion for investors and innovation teams.

Company Intelligence Q&A

What is NanoPass Technologies' primary focus?

NanoPass Technologies focuses on developing revolutionary solutions for intradermal delivery, utilizing proprietary technology to enhance therapeutic and medical aesthetic procedures.

When was NanoPass Technologies founded and by whom?

NanoPass Technologies was founded in April 2000 by Shuki Yeshurun.

What significant investment did NanoPass Technologies receive recently?

In July 2024, NanoPass Technologies secured a $4M investment from Awz Ventures, signaling growth and innovation in its intradermal delivery technology.

What is the MicronJet™ platform?

The MicronJet™ intradermal delivery product platform is NanoPass Technologies' proprietary technology designed to redefine the standard of care for precise, safe, and efficient therapeutic and medical aesthetic procedures.

What is NanoPass Technologies' upcoming product launch?

In January 2026, NanoPass Technologies will officially launch MicronJet™ 800 during IMCAS World 2026, expanding its product portfolio for intradermal delivery.